Skip to content

Other ways to search: Events Calendar | UTHSC News

Outcomes and Policy Research

Chisholm-Burns

Biography
Marie A. Chisholm-Burns, PharmD, MPH, MBA, FCCP, FASHP, FAST, is Dean and Professor of the University of Tennessee Health Science Center College of Pharmacy and Professor of Surgery in the College of Medicine. She received her BS in Psychology and General Studies (Emphasis in Biology) from Georgia College, BS in Pharmacy and Doctor of Pharmacy degrees from The University of Georgia, Master of Public Health from Emory University, and Master of Business Administration from the University of Memphis. She completed her residency at Mercer University Southern School of Pharmacy and at Piedmont Hospital in Atlanta, Georgia. Dr. Chisholm-Burns is Founder and Director of the Medication Access Program which increases medication access to transplant recipients. She has also served in numerous elected leadership positions in several different professional organizations, has worked in multiple pharmacy settings, and is a member of the National Academies of Practice. She serves as a member of government organizations, such as the Food and Drug Administration. With more than 310 publications and approximately $10 million in external funding as principal investigator from organizations such as the National Institutes of Health and several foundations, Dr. Chisholm-Burns is a prolific scholar. She has a broad background in pharmacy, with specific training and expertise in the following areas: (1) health care, medication, and medication therapy management access; (2) health disparities; (3) pharmacist-provided interventions to improve patient health and economic outcomes; (4) contributions of pharmacists to direct patient care; (5) medication adherence; (6) solid-organ transplant; and (7) scholarship of teaching and learning/education research.  In 2008 and 2011, textbooks co-edited by Dr. Chisholm-Burns, Pharmacotherapy Principles and Practice and Pharmacy Management, Leadership, Marketing, and Finance, respectively, received the Medical Book Award from the American Medical Writers Association. Additionally, she has received numerous awards and honors including the Robert K. Chalmers Distinguished Pharmacy Educator Award from the American Association of Colleges of Pharmacy (AACP), the Clinical Pharmacy Education Award from the American College of Clinical Pharmacy, the Daniel B. Smith Practice Excellence Award from the American Pharmacists Association (APhA), the Rufus A. Lyman Award for most outstanding publication in the American Journal of Pharmaceutical Education (1996 and 2007), the Nicholas Andrew Cummings Award from the National Academies of Practice, the Award of Excellence from the American Society of Health-System Pharmacists (ASHP), the Pharmacy Practice Research Award (2011 and 2014) and Award for Sustained Contributions to the Literature from the ASHP Foundation, the Research Achievement Award from APhA, the Clinician of Distinction Award from the American Society of Transplantation, the Paul R. Dawson Biotechnology Award from AACP, the Chauncey I. Cooper Pharmacist Leadership Award from the National Pharmaceutical Association, and the ASHP/Association of Black Health-Systems Pharmacists Joint Leadership Award. Dr. Chisholm-Burns is also a Fulbright Scholar.
Selected Publications

Peer-reviewed Journal Articles since 2012 (39 out of 140):

  1. Chisholm-Burns M, Erickson S, Spivey C, Kaplan B. Health-related quality of life and employment among renal transplant recipients. Clinical Transplantation 2012;26:411-417.
  1. Chisholm-Burns MA, Spivey CA, Billheimer D, Schlesselman LS, Flowers SK, Hammer D, Engle JP, Nappi J, Pasko MT, Ross LA, Sorofman B, Rodrigues HA, Vaillancourt AM. Multi-institutional study of women and underrepresented minority faculty in academic pharmacy: 20 years of successes, challenges, and opportunities. American Journal of Pharmaceutical Education 2012;76(1):Article 7.
  1. Chisholm-Burns M, Pinsky B, Parker G, Johnson P, Arcona A, Buzinec P, Chakravati P, Good M, Cooper M. Factors influencing immunosuppressant medication adherence in renal transplant recipients. Clinical Transplantation 2012;26:706-713.
  1. Chisholm-Burns MA, Spivey CA, Swift Martin J, Wyles C, Ehrman C, Schlesselman L. Five-year analysis of peer review publications of pharmacy practice faculty. American Journal of Pharmaceutical Education 2012;76(7): Article 127.
  1. Chisholm-Burns M, Spivey C. The “cost” of medication nonadherence: consequences we can no longer afford to accept. Journal of the American Pharmacists Association 2012; 52:823-826.
  1. Chisholm-Burns M, Spivey C, Sredzinski E, Butler S. Intervention toolbox to promote immunosuppressant therapy adherence in adult renal transplant recipients. Journal of the American Pharmacists Association 2012; 52:816-822.
  1. Gorevski E, Succop P, Sachdeva J, Cavanaugh T, Volek P, Heaton P, Chisholm-Burns M, Martin-Boone J. Is there an association between immunosuppressant therapy medication adherence and depression, quality of life, and personality traits in the kidney and liver transplant population? Patient Preference and Adherence 2013;7:301-307.
  1. Gourley DR, Vaidya VA, Hufstader MA, Ray MD, Chisholm-Burns MA. An international capstone experience for pharmacy students. American Journal of Pharmaceutical Education 2013;77:Article 50.
  1. Lee JK, Slack MK, Martin J, Ehrman C, Chisholm-Burns M. Geriatric patient care by U.S. pharmacists in healthcare teams: systematic review and meta analyses. Journal of the American Geriatric Society 2013;61(7):1119-1127.
  1. Chisholm-Burns MA, Spivey CA, Graff Zivin J, Lee JK, Sredzinski E, Tolley EA. Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. American Journal of Transplantation 2013;13:2364-2373.
  1. DiPiro JT, Chisholm-Burns MA. Fail fast. American Journal of Pharmaceutical Education 2013;77(8):Article 159.
  1. 12. Weng FL, Chandwani S, Kurtyka KM, Zacker C, Chisholm-Burns MA, Demisse K. Prevalence and correlates of medication non-adherence among kidney transplant recipients more than 6 months post-transplant. BMC Nephrology 2013;14:261.
  1. Spivey CA, Chisholm-Burns MA, Damadzadeh B, Billheimer D. Determining the effect of immunosuppressant adherence levels on graft failure risk among renal transplant recipients. ClinicalTransplantation 2014;28:96-104.
  1. Spivey CA, Chisholm-Burns MA, Garrett C, Duke KM. Serving underserved transplant recipients: experience of a medication access program. Patient Preference and Adherence 2014;8:613-619. 
  1. Wang J, Qiao Y, Shih YC, Spivey CA, Dagogo-Jack S, Wan JY, White-Means SI, Cushman WC, Chisholm-Burns MA. Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteria. Journal of PharmaceuticalHealth Services Research 2014;5(2):109-118.
  1. Tsapepas D, Langone A, Chan L, Wiland A, McCague K, Chisholm-Burns M*. A longitudinal assessment of adherence with immunosuppressive therapy following kidney transplantation from the Mycophenolic Acid Observational Renal Transplant (MORE) Study. Annals of Transplantation 2014;19:174-181. *senior author
  1. Brown RO, Spivey CA, Chisholm-Burns MA, Byrd DC. Three-year assessment of Advanced Pharmacy Practice Experience change requests at a large public college of pharmacy. Currents in Pharmacy Teaching and Learning 2014; 6:767-72.
  1. Chisholm-Burns M, Spivey CA, Phelps S, McDonough S, Byrd D. Evaluation of student factors associated with pre-NAPLEX scores. American Journal of Pharmaceutical Education 2014;78(10): Article 180.
  1. Wang J, Qiao Y, Shih YC, Jamison, JJ, Spivey CA, Wan JY, White-Means SI, Dagogo-Jack S, Cushman WC, Chisholm-Burns MA. Effects of Medicare Part D on disparity implications of medication therapy management eligibility criteria. American Health and Drug Benefits 2014;7:346-358.
  1. Wang J, Zhang Z, Spivey C, Chisholm-Burns M. Historical trend of racial and ethnic disparities in meeting Medicare medication therapy management eligibility in non-Medicare population. Research in Social and Administrative Pharmacy 2015;10:904-917.
  1. Farland MZ, Franks AS, Barlow PB, Rowe AS, Chisholm-Burns M. Assessment of student study patterns, performance, and long-term knowledge retention following use of didactive lecture compared to team-based learning. Currents in Pharmacy Teaching and Learning 2015;7(3):317-323. 
  1. Wang J, Shih Y-C, Qin Y, Young T, Thomas Z, Spivey CA, Solomon D, Chisholm-Burns M. Trends in Medicare Part D medication therapy management eligibility criteria. AmericanHealth & Drug Benefits 2015;8(5):247-255. 
  1. Chisholm-Burns M, Spivey CA. Factors associated with student pharmacist philanthropy to the college before and after graduation. American Journal of Pharmaceutical Education 2015;79(7): Article 102.
  1. Wang J, Qiao Y, Shih YC, Jarrett-Jamison J, Spivey CA, Wan JY, White-Means SI, Dagogo-Jack S, Cushman WC, Chisholm-Burns MA. Potential health implications of medication therapy management eligibility criteria in the Patient Protection and Affordable Care Act across racial and ethnic groups. Journal of Managed Care & Specialty Pharmacy 2015;31:993-1003.
  1. Chisholm-Burns M, Gatwood J, Spivey CA. Economic analysis of obtaining a PharmD degree and a career as a pharmacist. American Journal of Pharmaceutical Education 2015;79(8):Article 117.
  1. McDonough SLK, Alford EL, Finks SW, Parker RB, Chisholm-Burns MA, Phelps SJ. Student pharmacists’ perceptions of a composite examination in their first professional year. American Journal of Pharmaceutical Education 2016;80(1): Article 4. 
  1. Chisholm-Burns MA, Spivey CA, Tolley EA, Kaplan EK. Medication therapy management and adherence among US renal transplant recipients. Patient Preference and Adherence 2016;10:703-709.
  1. Chisholm-Burns MA, Gatwood J, Spivey CA, Dickey S. Break-even income analysis of pharmacy graduates compared to high school and college graduates. American Journal of Pharmaceutical Education 2016;80(3): Article 44. 
  1. Chisholm-Burns MA, Gatwood J, Spivey CA, Dickey S. Net income of pharmacy faculty compared to community and hospital pharmacists. American Journal of Pharmaceutical Education 2016;80(7): Article 117. 
  1. Madran BB, Karayurt Ö, Spivey CA, Chisholm-Burns MA*. Validity and reliability of the Immunosuppressant Therapy Adherence Scale in Turkish transplant recipients. Turkiye Klinikleri Journal of Nursing 2016;8(4):325-334. *senior author
  1. Woods TM, Acosta WR, Chung EP, Cox AG, Garcia GA, Klucken JR, Chisholm-Burns MA*. Academic freedom should be redefined: point and counterpoint. American Journal of Pharmaceutical Education 2016;80(9): Article 146. *senior author
  1. Wang J, Qiao Y, Spivey C, Li C, Clark C, Den Y, Liu F, Tillman J, Chisholm-Burns M. Disparity implications of proposed 2015 Medicare eligibility criteria for medication therapy management services. Journal of Pharmaceutical Health Services Research 2016; 7(4):209-215. 
  1. Chisholm-Burns MA, Spivey CA, Hagemann T, Josephson MA. Women in leadership and the bewildering glass ceiling. American Journal of Health-System Pharmacy 2017;74:312-324. 
  1. Hohmeier K, Spivey C, Chisholm-Burns M. A community-based partnership collaborative practice agreement project to teach innovation in care delivery. Currents in Pharmacy Teaching and Learning 2017;9:473-478. 
  1. Chisholm-Burns MA, Spivey CA, Gatwood J, Wiss A, Hohmeier K, Erickson SR. Evaluation of racial and socioeconomic disparities in medication pricing and pharmacy access and services. American Journal of Health-System Pharmacy 2017;74(10):653-668. 
  1. Chisholm-Burns MA, Spivey CA, Jaeger M, Williams J, George C. Development of an instrument to measure pharmacy student attitudes toward social media professionalism. American Journal of Pharmaceutical Education 2017;81(4): Article 65. 
  1. Chisholm-Burns MA, Spivey CA, Byrd DC, McDonough SLK, Phelps SJ. Examining the association between the NAPLEX, Pre-NAPLEX, and pre and post admission factors. American Journal of Pharmaceutical Education 2017;81(5): Article 86.
  1. Hohmeier KC, Spivey CA, Boldin S, Moore TB, Chisholm-Burns M. Implementation of a health information exchance into community pharmacy workflow. Journal of the American Pharmacists Association 2017;57:608-615. 
  1. Chisholm-Burns MA, Spivey CA, Jaeger MC, Williams, JS. Associations between pharmacy students’ attitudes toward debt, stress, and student loans. American Journal of Pharmaceutical Education 2017;81(7): Article 5918.

 

Books (4 out of 17):

  1. Chisholm-Burns MA, Vaillancourt A, Shepherd M (eds.). Pharmacy Management, Leadership, Marketing, and Finance. 2nd ed. Burlington, MA: Jones and Bartlett Learning; 2014.
  1. Chisholm-Burns MA, Schwinghammer TL, Wells BG, Malone PM, Kolesar JM, DiPiro JT (eds). Pharmacotherapy Principles and Practice. 4th Edition. New York: McGraw-Hill; 2016. 
  1. Katz MD, Matthias KR, Chisholm-Burns MA (eds.). Pharmacotherapy Principles and Practice Study Guide. A Care Plan Approach. 4th Edition. New York: McGraw-Hill; 2016. 

4. Chisholm-Burns MA.  How to Prepare for the PCAT. 7th Edition. Hauppauge, NY: Barron’s Educational Series, Inc.; 2017. (360 pages).

 

Gatwood

Description

Dr. Gatwood’s overarching focus is on improving medication adherence and health outcomes associated with chronic disease. His work approaches this from two distinct yet related methods: 1) identifying populations with poor medication use and determining the factors related to nonadherence using database analyses; and 2) developing and testing technology-focused behavioral interventions aimed at improving medication use and other health-related behaviors. While at UTHSC, this has included analyzing veterans’ antidiabetic medication use patterns for racial and regional variation in adherence and outcomes, testing the effectiveness of tailored text messages to improve diabetes self-care activities among underserved African American adults with diabetes, using real-time mobile monitoring to improve glaucoma medication adherence, determining the impact of clinical pharmacy services on medication use and short-term health outcomes, and, most recently, examining oral anticancer medication adherence and its initiation on adherence to other chronic disease medications.

Dr. Gatwood can be reached at jgatwood@utshc.edu or 615-532-3403.
Members and Collaborators

Dr. Csaba Kovesdy, UTHSC College of Medicine (Nephrology) and Memphis VA Medical Center

Dr. Jim Bailey, UTHSC College of Medicine (Internal Medicine)
Projects
  • Improving Self-Care Decisions of Medically Underserved African-Americans with Uncontrolled Diabetes: Effectiveness of Patient-Driven Text Messaging versus Health Coaching (PI: Jim Bailey; PCORI Project Program Award SC15-1503-28336)
  • The influence of race on medication adherence and health outcomes in veterans with diabetes (UTHSC iRISE KL2) 
  • Leveraging Real-Time Medication Use Monitoring to Improve Adherence in Adults With Glaucoma (ClinicalTrials.gov: NCT03194828)
Selected Publications
  1. Gatwood J, Chisholm-Burns M, Davis R, Thomas F, Potukuchi P, Hung A, Kovesdy CP. Disparities in Initial Oral Antidiabetic Medication Adherence among Veterans with Incident Diabetes.  J Manag Care Spec Pharm (in press)
  2. Gatwood J, Johnson J, Jerkins B. Adherence to topical glaucoma medication: Comparing a new wireless device and self-reported measures. J Glaucoma (in press)
  3. Gatwood J, Hohmeier KC, Farr G, Eckel SF. A Comparison of Approaches to Student Pharmacist Business Planning in Pharmacy Practice Management. Am J Pharm Educ (epub ahead of print). Article ajpe6279
  4. Gatwood J, Gatwood K, Gabre E, Alexander M. Impact of clinical pharmacists in outpatient oncology practices: A review. Am J Health Syst Pharm 2017; 74(19): 1549-1557. 
  5. Gatwood J, Balkrishnan R, Erickson SR, An LC, Piette JD, Farris KB. The impact of tailored text messages on health beliefs and medication adherence in adults with diabetes: A randomized pilot study. Res Soc Adm Pharm 2016; 12(1): 130-140. PubMed PMID: 25980582.

 

 

 

Spivey

Biography

Christina A. Spivey, PhD, LMSW, is an Assistant Professor in the Department of Clinical Pharmacy and Translational Science of the University of Tennessee Health Science Center College of Pharmacy and a member of the UTHSC Institute of Health Outcomes and Policy. She received a PhD in Social Work from The University of Georgia, a Master of Social Service Administration degree from the University of Chicago, and a Bachelor’s degree in Justice from American University. Dr. Spivey has more than 60 publications (peer-reviewed journal articles and book chapters) spanning such fields as social work, geriatrics, public health, and pharmacy. Her research efforts are largely focused on (1) medication adherence and related outcomes in chronic disease state patient populations such as transplant and atrial fibrillation; (2) disparities and outcomes associated with medication therapy management; (3) medication access; and (4) academic pharmacy and scholarship of teaching and learning. She has served as Co-Principal Investigator and Co-Investigator on competitive extramural grants from multiple funding agencies including the NIH, foundations, and industry. She served as co-author on two projects which received the Pharmacy Practice Research Award (2011 and 2014) from the American Society of Health-System Pharmacists (ASHP) Foundation.

Selected Publications

Peer-reviewed Journal Articles since 2012 (33 of 58 total):

  1. Chisholm-Burns, M., Erickson, S., Spivey, C., & Kaplan, B. (2012). Health-related quality of life and employment among renal transplant recipients. Clinical Transplantation,26, 411-417.
  1. Chisholm-Burns, M.A., Spivey, C.A., Billheimer, D., Schlesselman, L.S., Flowers, S.K., Hammer, D., Engle, J.P., Nappi, J., Pasko, M.T., Ross, L.A., Sorofman, B., Rodrigues, H.A., & Vaillancourt, A.M. (2012). Multi-institutional study of women and underrepresented minority faculty in academic pharmacy: 20 years of successes, challenges, and opportunities. American Journal of Pharmaceutical Education,76(1), Article 7. 
  1. Chisholm-Burns, M.A., Spivey, C.A., Martin, J., Wyles, C., Ehrman, C., & Schlesselman, L. (2012). Five-year analysis of peer review publications of pharmacy practice faculty. American Journal of Pharmaceutical Education, 76(7), Article 127.
  1. Chisholm-Burns, M., & Spivey, C. (2012). The “cost” of medication nonadherence: consequences we can no longer afford to accept. Journal of the American Pharmacists Association, 52, 823-826
  1. Chisholm-Burns, M., Spivey, C., Sredzinski, E., & Butler, S. (2012). Intervention toolbox to promote immunosuppressant therapy adherence in adult renal transplant recipients. Journal of the American Pharmacists Association, 52, 816-822.
  1. Chisholm-Burns, M.A., Spivey, C.A., Graff Zivin, J., Lee, J.K., Sredzinski, E. & Tolley, E.A. (2013). Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. American Journal of Transplantation,13, 2364-2373.
  1. Spivey, C.A., Chisholm-Burns, M.A., Damadzadeh, B, & Billheimer, D. (2014). Determining the effect of immunosuppressant adherence levels on graft failure risk among renal transplant recipients. Clinical Transplantation,28, 96-104.
  1. Spivey, C.A., Chisholm-Burns, M.A., Garrett, C., & Duke, K.M. (2014). Serving underserved transplant recipients: experience of a medication access program. Patient Preference and Adherence, 8, 613-619.
  1. Wang, J., Qiao, Y., Shih, Y.C., Spivey, C.A., Dagogo-Jack, S., Wan, J.Y., White-Means, S.I., Cushman, W.C., & Chisholm-Burns, M.A. (2014). Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteria. Journal of PharmaceuticalHealth Services Research,5(2), 109-118.
  1. Brown, R.O., Spivey, C.A., Chisholm-Burns, M.A., & Byrd, D.C. (2014). Three-year assessment of Advanced Pharmacy Practice Experience change requests at a large public college of pharmacy. Currents in Pharmacy Teaching and Learning, 6, 767-72.
  1. Chisholm-Burns, M., Spivey, C.A., Phelps, S., McDonough, S., & Byrd, D. (2014). Evaluation of student factors associated with pre-NAPLEX scores. American Journal of Pharmaceutical Education, 78(10), Article 180.
  1. Wang, J., Qiao, Y., Shih, Y.C., Jamison, J.J., Spivey, C.A., Wan, J.Y., White-Means, S.I., Dagogo-Jack, S., Cushman, W.C., & Chisholm-Burns MA. (2014). Effects of Medicare Part D on disparity implications of medication therapy management eligibility criteria. American Health and Drug Benefits, 7(6), 346-358. 
  1. Wang, J., Zhang, Z., Spivey, C., & Chisholm-Burns, M. (2015). Historical trend of racial and ethnic disparities in meeting Medicare medication therapy management eligibility in non-Medicare population. Research in Social and Administrative Pharmacy, 10(6), 904-917. 
  1. Geiger, J.R., Wilks, S.E., Lovelace, L.L., Chen, Z., & Spivey, C.A. (2015). Burden among male, Alzheimer’s caregivers: Effects of distinct coping strategies. American Journal of Alzheimer’s Disease & Other Dementias, 30(3), 238-246.
  1. Spivey, C.A., Qiao, Y., Liu, J., Mardekian, J., Parker, R.B., Phatak, H., Claflin, A.B., Kachroo, S., Abdulsattar, Y., Chakrabarti, A., & Wang, J. (2015). Discontinuation/interruption of warfarin therapy in patients with non-valvular atrial fibrillation. Journal of Managed Care & Specialty Pharmacy, 21(7), 596-606. 
  1. Spivey, C.A., Liu, X., Qiao, Y., Mardekian, J., Parker, R.B., Phatak, H., Masseria, C., Kachroo, S., Abdulsattar, Y., & Wang, J. (2015). Stroke associated with discontinuation of warfarin therapy for atrial fibrillation. Current Medical Research and Opinion, 31(11), 2021-2029.
  1. Wang, J., Shih, Y-C., Qin, Y., Young, T., Thomas, Z., Spivey, C.A., Solomon, D., & Chisholm-Burns, M. (2015). Trends in Medicare Part D medication therapy management eligibility criteria. American Health & Drug Benefits, 8(5), 247-255. 
  1. Chisholm-Burns, M., & Spivey, C.A. (2015). Factors associated with student pharmacist philanthropy to the college before and after graduation. American Journal of Pharmaceutical Education, 79(7), Article 102. 
  1. Wang, J., Qiao, Y., Shih, Y.C., Jarrett-Jamison, J., Spivey, C.A., Wan, J.Y., White-Means, S.I., Dagogo-Jack, S., Cushman, W.C., & Chisholm-Burns M.A. (2015). Potential health implications of medication therapy management eligibility criteria in the Patient Protection and Affordable Care Act across racial and ethnic groups. Journal of Managed Care and Specialty Pharmacy, 21(11), 993-1003.
  1. Chisholm-Burns, M., Gatwood, J., & Spivey, C.A. (2015). Economic analysis of obtaining a PharmD degree and a career as a pharmacist. American Journal of Pharmaceutical Education,79(8), Article 117. 
  1. Chisholm-Burns, M.A., Spivey, C.A., Tolley, E.A., & Kaplan, E.K. (2016). Medication therapy management and adherence among US renal transplant recipients. Patient Preference and Adherence, 10, 703-709.
  1. Chisholm-Burns, M.A., Gatwood, J., Spivey, C.A., & Dickey, S.E. (2016). Break-even income analysis of pharmacy graduates compared to high school and college graduates. American Journal of Pharmaceutical Education, 80(3), Article 44. 
  1. Chisholm-Burns, M.A., Gatwood, J., Spivey, C.A., & Dickey, S. (2016). Net income of pharmacy faculty compared to community and hospital pharmacists. American Journal of Pharmaceutical Education, 80(7), Article 117. 
  1. Spivey, C.A., Liu, X., Qiao, Y., Mardekian, J., Parker, R.B., Phatak, H., Masseria, C., Kachroo, S., Abdulsattar, Y., & Wang, J. (2016.) Economic outcomes of warfarin discontinuation among patients with atrial fibrillation. American Journal of Pharmacy Benefits,8(4), 141-148.
  1. Madran, B.B., Karayurt, Ö., Spivey, C.A., & Chisholm-Burns, M.A. (2016.) Validity and Reliability of the Immunosuppressant Therapy Adherence Scale in Turkish Transplant Recipients. Turkiye Klinikleri Journal of Nursing, 8(4), 325-334.
  1. Wang, J., Qiao, Y., Spivey, C., Li, C., Clark, C., Den, Y., Liu, F., Tillman, J., & Chisholm-Burns, M. (2016.) Disparity implications of proposed 2015 Medicare eligibility criteria for medication therapy management services. Journal of Pharmaceutical Health Services Research,7(4), 209-215. 
  1. Chisholm-Burns, M.A., Spivey, C.A., Hagemann, T., & Josephson, M.A. (2017.) Women in leadership and the bewildering glass ceiling. American Journal of Health-System Pharmacy, 74(5) 312-324.
  1. Hohmeier, K., Spivey, C., & Chisholm-Burns, M. (2017.) A community-based partnership collaborative practice agreement project to teach innovation in care delivery. Currents in Pharmacy Teaching and Learning, 9, 473-478. 

29. Chisholm-Burns, M.A., Spivey, C.A., Gatwood, J., Wiss, A., Hohmeier, K., & Erickson, S.R. (2017). Evaluation of racial and socioeconomic disparities in medication pricing and pharmacy access and services. American Journal of Health-System Pharmacy, 74(10), 653-668.

  1. Chisholm-Burns, M.A., Spivey, C.A., Jaeger, M., Williams, J., & George, C. (2017). Development of an instrument to measure pharmacy student attitudes toward social media professionalism. American Journal of Pharmaceutical Education,81(4), Article 65. 
  1. Chisholm-Burns, M.A., Spivey, C.A., Byrd, D.C., McDonough, S.L.K., & Phelps, S.J. (2017). Examining the association between the NAPLEX, Pre-NAPLEX, and pre and post admission factors. American Journal of Pharmaceutical Education, 81(5), Article 86.
  1. Hohmeier, K.C., Spivey, C.A.*, Boldin, S., Moore, T.B., & Chisholm-Burns, M. (2017). Implementation of a health information exchance into community pharmacy workflow. Journal of the American Pharmacists Association, 57(5), 608-615. *corresponding author
  1. Chisholm-Burns, M.A., Spivey, C.A., Jaeger, M.C., & Williams, J.S. (2017). Associations between pharmacy students’ attitudes toward debt, stress, and student loans. American Journal of Pharmaceutical Education 81(7), Article 5918.

 

Wang

Description
Junling Wang, PhD, is a Professor in Health Outcomes and Policy Research at the University of Tennessee Health Science Center, College of Pharmacy. She received her PhD in Pharmaceutical Health Services Research from the University of Maryland in 2005. Dr. Wang has continuously concentrated on the following two research areas: (1) outcomes/economic evaluation of pharmaceutical products and services including medication therapy management; and (2) racial and ethnic disparities in the utilization of health services and prescription drugs. Her research has been funded by the National Institutes of Health (NIH)/National Institute on Aging, Pharmacy Quality Alliance, Pharmaceutical Research and Manufacturers of America Foundation, American Association of Colleges of Pharmacy, Pfizer Inc., Bristol-Myers Squibb, Eli Lilly and Company, and the State of Tennessee. Dr. Wang has published over 50 research articles in peer-reviewed journals. Her work has been cited by the Federal government as reasons for federal policy reform for the Medicare eligibility criteria for medication therapy management services. She has also received recognition for her research including the Nobuo Meade International Research Award and an Honorable Mention for Betty J. Cleckley Minority Issues Research Award from the American Public Health Association (APHA) Aging and Public Health Section. Dr. Wang’s leadership roles have included the APHA Aging and Public Health Section Program Chair, Membership Chair, governing councilor, and Nominations Committee.
Lab Personnel
Research Assistant: Yanru Qiao, MS
Projects
  • “Reducing racial/ethnic disparities in Alzheimer’s-Type dementia with MTM services.” Source: NIA/NIH. 08/2020-12/2021. $380,000. Role: Principal Investigator. 

  •  

    “Equity and Economic Effects of MTM Services.” Source: NIA/NIH. 02/2019-12/2022. $1,405,107. Role: Principal Investigator. 

     

  • “Finding Solutions for Disparities Associated with Star Ratings.” Source: NIA/NIH. 09/2018-06/2023. $1,672,000. Role: Principal Investigator. 

  •  

    “Outcomes of cumulative medication review for Medicare medication therapy management services.” Source: Pharmacy Quality Alliance. 09/2019-05/2010. $1,000. Role: Principal Investigator. 

  •  

    “Finding Effective and Equitable MTM Eligibility Criteria.” Source: NIA/NIH. 08/2015-04/2019. $987,562. Role: Principal Investigator. 

Selected Publications

Current and recent publications for past five years (2017-2022)

1. Tsang CCS, Browning J, Todor L, Dougherty S, Hohmeier K, Li M, Borja-Hart N, Hines L, Wang J. Factors associated with medication nonadherence among Medicare low-income subsidy beneficiaries with diabetes, hypertension, and/or heart failure. Journal of Managed Care and Specialty Pharmacy. 2021;27(8):971-981. doi: 10.18553/jmcp.2021.27.8.971. 

2. Browning J, Tsang CCS, Wan JY, Chisholm-Burns MA, Dagogo-Jack S, Cushman WC, Dong X, Wang J. Racial and ethnic disparities associated with the measure for drug-drug interactions among Medicare beneficiaries. Journal of the American Pharmacists Association (2003). 2021;S1544-3191(21)00364-2. doi: 10.1016/j.japh.2021.08.023. [Epub ahead of print]  

3. Qiao Y, Steve Tsang CC, Hohmeier KC, Dougherty S, Hines L, Chiyaka ET, Wang J. Association between medication adherence and healthcare costs among patients receiving the low-income subsidy.Value in Health. 2020;23(9):1210-1217.  

4. Li M, Schulz R, Chisholm-Burns M, Wang J, Lu ZK. Racial/ethnic and gender disparities in the use of erythropoiesis-stimulating agents and blood transfusions: cancer management under Medicare’s reimbursement policy. Journal of Managed Care & Specialty Pharmacy. 2020;26(11):1477-1486. 

5. Spivey CA, Griffith J, Kaplan C, Postlethwaite A, Ganguli A, Wang J. Retrospective analysis of the impact of adalimumab initiation on corticosteroid utilization and medical costs among biologic-naïve patients with rheumatoid arthritis. Rheumatology & Therapy. 2019 Nov 18. doi: 10.1007/s40744-019-00184-5. [Epub ahead of print] 

6. Spivey CA, Qiao Y, Wang J, Shih YT, Wan JY, Dagogo-Jack S, Cushman WC, Hines LE, Chisholm-Burns MA. Comparative effectiveness of medication therapy management eligibility criteria across racial/ethnic groups. Journal of the American Geriatrics Society. 2019;67(3):581-587. 

7. Qiao Y, Spivey CA, Wang J, Shih YT, Wan JY, Kuhle J, Dagogo-Jack S, Cushman WC, Chisholm-Burns MA. Higher predictive value positive for MMA than ACA MTM eligibility criteria among racial and ethnic minorities: An Observational Study. Inquiry. 2018;55:46958018795749. doi: 10.1177/0046958018795749. 

8. Spivey CA, Wang J, Qiao Y, Shih YT, Wan JY, Kuhle J, Dagogo-Jack S, Cushman WC, Chisholm-Burns M. Racial and ethnic disparities in meeting MTM eligibility criteria based on Star Ratings compared with the Medicare Modernization Act. Journal of Managed Care & Specialty Pharmacy. 2018;24(2):97-107. 

9. Spivey CA, Griffith J, Kaplan C, Postlethwaite A, Ganguli A, Wang J. A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States. Rheumatology & Therapy. 2017 Dec 4. doi: 10.1007/s40744-017-0089-8. [Epub ahead of print] 

10. Lu D, Qiao Y, Brown NE, Wang J. Racial and ethnic disparities in influenza vaccination among adults with chronic medical conditions vary by age in the United States. PLoS One. 2017 Jan 12;12(1):e0169679. doi: 10.1371/journal.pone.0169679. 

Jun 21, 2022